- Credit Type: CPE
- Credit Amount: 1.00
- Cost: $5.00
- Release: Feb 9, 2015
- Expires: Oct 23, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Pharmacy Practice and Science
College of Pharmacy
Associate Professor Joint Appointment
Department of Neurology
College of Medicine
University of Kentucky
Neurology Clinical Pharmacy Specialist VAMC
Needs StatementAlzheimer’s disease (AD) is a common disorder with limited treatment modalities. Practitioners must understand current treatments and those in development to improve quality of pharmaceutical use for AD.
ObjectivesUpon Completion of this activity Pharmacist will be able to:
1. Describe the amyloid pathway hypothesis for Alzheimer’s disease
2. Appraise the clinical utility of currently available treatments for Alzheimer’s disease
3. Discuss potential treatments for Alzheimer’s disease in the future
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based activity has been assigned UAN 0022-0000-15-021-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.
Faculty DisclosureMelody Ryan, PharmD (Speaker) has no relevant financial relationships with any commercial interests.
Melody Ryan does not intend to discuss the off-label use of a product.
No planners have any relevant financial relationships to disclose.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.